L&C BIO

290650 · KOSDAQ · Health Care · SMALL CAP

Trading suspension (bonus issue)

The exchange suspended trading in L&C BIO's common shares from 15:56 on 2026-07-31 until market close due to a bonus share issue, under KOSDAQ Market Disclosure Regulation Article 37 and its Enforcement Rules Article 18.

Capital raise(Trading suspension (bonus issue))· FILED 2026-07-31· RCEPT 20260731900868

What happened

Trading suspension of shares

1. Target security: L&C BIO Co., Ltd. common shares

2. Reason for suspension: Bonus issue

3. Suspension period (a) Suspension date/time: 2026-07-31 15:56:00 (b) Expiration date/time: Until market close

4. Applicable regulation: KOSDAQ Market Disclosure Regulation Article 37 and Enforcement Rules of the same Regulation, Article 18

5. Other: Pursuant to Article 26 of the Enforcement Rules of the KOSDAQ Market Business Regulation, off-hours trading before market open on the day trading resumes will not be executed.

Filed2026-07-31, Trading suspension (bonus issue)
SourceDART rcept 20260731900868 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-31 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).